Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 5/20 | 0.60 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.58 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.58 |
| ▸ | CPA3 | P15088 | 1/20 | 0.53 |
| ▸ | GGH | Q92820 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL869873 | 1.00 | NAALAD2 (0.60) | NAALAD2FOLH1MEP1BCPA3GGH | |
| SCHEMBL1818651 | 1.00 | NAALAD2 (0.60) | NAALAD2FOLH1MEP1BCPA3GGH | |
| SCHEMBL30213700 | 0.91 | NAALAD2 (0.51) | NAALAD2FOLH1MEP1BCPA3GGH | |
| SCHEMBL31419850 | 0.88 | MEP1B (0.61) | NAALAD2FOLH1MEP1BCPA3GGH | |
| SCHEMBL461572 | 0.87 | KMT2A (0.54) | NAALAD2FOLH1MEP1BMMP9MMP8 | |
| SCHEMBL461571 | 0.87 | KMT2A (0.54) | NAALAD2FOLH1MEP1BMMP9MMP8 | |
| SCHEMBL2251929 | 0.87 | MEP1B (0.52) | NAALAD2FOLH1MEP1BCPA3GGH | |
| SCHEMBL6566486 | 0.85 | FOLH1 (0.61) | NAALAD2FOLH1MEP1BGAAMMP9 | |
| SCHEMBL5577137 | 0.85 | MEP1B (0.48) | NAALAD2FOLH1MEP1BGGHRIMKLA | |
| SCHEMBL5577139 | 0.85 | MEP1B (0.48) | NAALAD2FOLH1MEP1BGGHRIMKLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150232616-A1 | HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS | INTEZYNE TECHNOLOGIES, INC. | 2015-08-20 | — | — | US | claimed |
| US-8980326-B2 | Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents | INTEZYNE TECHNOLOGIES, INC. (US) | 2015-03-17 | — | — | US | claimed |
| EP-2359862-B1 | Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents | INTEZYNE TECHNOLOGIES INC (US) | 2013-07-24 | — | — | EP | claimed |
| US-20100324259-A1 | HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS | INTEZYNE TECHNOLOGIES, INC. (US) | 2010-12-23 | — | — | US | claimed |
| EP-2073850-B1 | HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS | INTEZYNE TECHNOLOGIES INC (US) | 2010-10-27 | — | — | EP | claimed |
| US-12254963-B2 | Method for determination of the anisotropic parameters for the configuration of organic molecules embedded in alignment media | MAX-PLACK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2025-03-18 | — | — | US | disclosed |
| WO-2023227633-A1 | AMPHIPHILIC POLY(AMINO ACID) LINEAR BLOCK COPOLYMERS AND NANOPARTICLES THEREOF FOR DRUG DELIVERY APPLICATIONS | NANOTHERA BIOSCIENCES, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| CN-109844971-B | Structure for piezoelectric element, string-like piezoelectric element, cloth-like piezoelectric element, and device using same | 帝人株式会社 | 2023-07-28 | — | — | CN | disclosed |
| US-20230067122-A1 | Method for Determination of the Anisotropic Parameters for the Configuration of Organic Molecules Embedded in Alignment Media | MAX-PLACK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2023-03-02 | — | — | US | disclosed |
| EP-4090956-A1 | METHOD FOR DETERMINATION OF THE ANISOTROPIC PARAMETERS FOR THE CONFIGURATION OF ORGANIC MOLECULES EMBEDDED IN ALIGNMENT MEDIA | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-11-23 | — | — | EP | disclosed |
| US-11339130-B1 | Calpain modulators and therapeutic uses thereof | BLADE THERAPEUTICS, INC. (US) | 2022-05-24 | — | — | US | disclosed |
| US-10934261-B2 | Calpain modulators and therapeutic uses thereof | BLADE THERAPEUTICS, INC. (US) | 2021-03-02 | — | — | US | disclosed |
| WO-2013154774-A1 | BLOCK COPOLYMERS FOR STABLE MICELLES | INTEZYNE TECHNOLOGIES, INC. (US) | 2013-10-17 | — | — | WO | disclosed |
| EP-1392755-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| EP-1392756-A2 | LIPID-POLYMER-CONJUGATES | Yamanouchi Europe B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002098952-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002098951-A2 | LIPID-POLYMER-CONJUGATES | YAMANOUCHI EUROPE B.V. (NL) | 2002-12-12 | — | — | WO | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-4127540-A | Novel derivatives of δ-endorphins, intermediates therefor, and compositions and methods employing said derivatives | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10934261-B2 | Calpain modulators and therapeutic uses thereof | CAPNS1, CAPN9, CAPN1 | NAALAD2 604/4885FOLH1 1680/4885MEP1B 1421/4885 |
| US-11339130-B1 | Calpain modulators and therapeutic uses thereof | CAPNS1, CAPN9, CAPN1 | NAALAD2 604/4885FOLH1 1680/4885MEP1B 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.